| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2005-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
293,395 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,088 |
321,599 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
393,324 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
400,854 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
836,831 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
870,873 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,000 |
896,329 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
913,361 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
1,881,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
204,088 |
1,675,552 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
26,468 |
1,699,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,500 |
1,538,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
109,475 |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-04 |
4 |
GA |
$0.00 |
$0 |
D/D |
28,124 |
1,029,793 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-27 |
5 |
GA |
$0.00 |
$0 |
D/D |
480 |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-13 |
5 |
GA |
$0.00 |
$0 |
D/D |
9,726 |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,040 |
991,316 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,100 |
1,032,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
33,990 |
958,708 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,300 |
966,608 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
950,126 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
99,829 |
749,259 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,805 |
759,802 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
406,299 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-08-23 |
4 |
OE |
$2.38 |
$69,272 |
D/D |
29,167 |
226,312 |
|
- |
|
283 Records found
|
|
Page 1 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
